Evidence map›Paper›PMID 35170309›Full record

ArticleACS infectious diseases2022

Virus-like Particle Display of

Zahra Rashidijahanabad, Meagan Kelly, Mohammad Kamruzzaman, Firdausi Qadri, Taufiqur R Bhuiyan, Hunter McFall-Boegeman, Di Wu, Grzegorz Piszczek, Peng Xu, Edward T Ryan and 1 more

Open access · greenAbstract read
In one paragraph

Article in ACS infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Glycan-costumed virus-like particles promote type 1 anti-tumor immunity.bioRxiv : the preprint server for biology · 2024
    Article
  10. Review
  11. Diacylglycerol-dependent hexamers of the SNARE-assembling chaperone Munc13-1 cooperatively bind vesicles.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Review
  13. Intracellular Expression of CTB inJournal of microbiology and biotechnology · 2023
    Article
  14. Review
  15. Frontiers in medicine · 2023
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Zahra RashidijahanabadDepartment of Chemistry, Michigan State University, East Lansing, Michigan 48824, United States.
Meagan KellyDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Mohammad KamruzzamanInternational Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka 1212, Bangladesh.
Firdausi QadriInternational Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka 1212, Bangladesh.
Taufiqur R BhuiyanInternational Centre for Diarrheal Disease Research Bangladesh (icddr,b), Dhaka 1212, Bangladesh.
Hunter McFall-BoegemanDepartment of Chemistry, Michigan State University, East Lansing, Michigan 48824, United States.
Di WuBiophysics Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.
Grzegorz PiszczekBiophysics Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.
Peng XuLaboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.
Edward T RyanDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Xuefei HuangDepartment of Chemistry, Michigan State University, East Lansing, Michigan 48824, United States.ORCID 0000-0002-6468-5526
International Centre for Diarrhoeal Disease Research · BDMichigan State University · USNational Institutes of Health · USHarvard University · USMassachusetts General Hospital · US

Funding

Training program in vaccine development and public healthD43TW005572 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI QADRI, FIRDAUSI, RYAN, EDWARD T. · 2000 to 2025
$5.4M
O-Specific Polysaccharide Responses and CholeraR37AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Edward T. Ryan · 2020 to 2026
$5.1M
O-Specific Polysaccharide Responses and CholeraR01AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2014 to 2018
$3.7M
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccinesR01AI146210 · NIAID · MICHIGAN STATE UNIVERSITY · PI HUANG, XUEFEI · 2019 to 2023
$1.5M
Humoral and adaptive immune responses study in Vibrio cholerae infectionK43TW010362 · FIC · INTERNATIONAL CTR/DIARRHOEAL DIS RES · PI BHUIYAN, MD TAUFIQUR RAHMAN · 2016 to 2020
$359k
FIC NIH HHS D43 TW005572FIC NIH HHS K43 TW010362NIAID NIH HHS R01 AI106878NIAID NIH HHS R01 AI146210NIAID NIH HHS R37 AI106878
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CholeraCholera VaccinesVibrio cholerae O1AnimalsAntibodies, BacterialImmunoglobulin AImmunoglobulin GImmunoglobulin MMiceO AntigensAntibodies, BacterialCholera VaccinesImmunoglobulin AImmunoglobulin GImmunoglobulin MO Antigensbacteriophage Qβmass photometryO-specific polysaccharidevaccineVibrio cholera

Identifiers

PMID35170309
PMCPMC9119010
OpenAlexW4212820450

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.